- Full Time Employees
- 796
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Karabaglar Turkey
- IPO Date
- Jul 2, 2021
- Business
- Meditera Tibbi Malzeme Sanayi Ve Ticaret A.S. is a Turkey-based medical device manufacturer and distributor specializing in the design, development, and production of single-use medical consumables, respiratory care systems, and hazardous drug preparation technologies. Founded in 1983 and headquartered in Izmir, Turkey, the company operates in the medical technology and healthcare supplies sector, serving public and private hospitals, healthcare institutions, and distributors worldwide. Meditera offers a comprehensive portfolio organized into key product categories, including respiratory and anesthesia products, such as anesthesia breathing circuits, mechanical ventilator sets, heat and moisture exchanger (HME) filters, bacterial and viral breathing filters, catheter mounts, manual resuscitators, and oxygen therapy masks; infusion therapy and vascular access solutions, such as gravity infusion sets, IV extension lines, stopcocks, needleless connectors, blood transfusion sets, and specialized closed system drug transfer devices (CSTD) for the safe compounding and administration of hazardous cytotoxic oncology drugs; surgical drainage and suction devices, such as surgical suction connecting tubes, yankauer handles, and wound drainage systems; and blood collection and laboratory consumables, including vacuum blood collection tubes and in-vitro diagnostic products manufactured through affiliated entities such as Altech and Disera. The company also provides contract manufacturing services, including original equipment manufacturer (OEM) and original design manufacturer (ODM) solutions for global medical brands. Meditera operates specialized manufacturing and cleanroom facilities in the Tire Organized Industrial Zone in Izmir, distributing domestically and exporting to more than 80 countries across Europe, the Middle East, Asia, and the Americas. In recent developments, the company has completed major cleanroom and manufacturing automation expansions at its Izmir production campus to scale output for high-margin closed system drug transfer devices and respiratory circuits; advanced its product portfolio through the European Union Medical Device Regulation (MDR) certification process; expanded international commercial distribution networks and OEM partnership agreements with multinational healthcare corporations across Europe; and introduced next-generation oncology drug preparation and delivery product variants to strengthen healthcare personnel safety protocols against hazardous chemical exposure.